Clinical trial
MRI to Detect Breast Tumors in Women
NCT00003302
Study timeline
Study start (unknown)1998-05-01Date precision: month
Registry last updated2019-09-25
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
Sponsors & collaborators
Abramson Cancer Center at Penn Medicinelead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
HoustonTexas, United States1BostonMassachusetts, United States1Los AngelesCalifornia, United States1PhiladelphiaPennsylvania, United States1DallasTexas, United States1BaltimoreMaryland, United States1TorontoOntario, Canada1San FranciscoCalifornia, United States1DenverColorado, United States1Chapel HillNorth Carolina, United States1Little RockArkansas, United States1BuffaloNew York, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00003302 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.